FDAnews
www.fdanews.com/articles/108727-fda-approves-exalenz-liver-trial

FDA Approves Exalenz Liver Trial

July 21, 2008
Exalenz Bioscience has obtained US Food and Drug Administration (FDA) approval to begin the Phase III clinical trial for the company’s BreathID diagnostic device for liver damage.
Globes